Welltass Pharmaceuticals Private Limited
About Welltass Pharmaceuticals Private Limited
Data last updated:
Welltass Pharmaceuticals Private Limited is a private limited company based in Greater Noida, Uttar Pradesh, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 18 February 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U24233UP2015PTC069030. Its GSTIN is 09AABCW6159Q1ZG (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Moinuddin (Whole-Time Director) and Farhana Parveen.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Vill – Begumpur, Greater Noida, Uttar Pradesh, India – 201306.
As per the financials filed for FY 2025, the company reported a revenue of ₹39.92 Lakh, a decline of 6% compared to the previous year. For the same year it recorded a net loss of ₹1.59 Lakh (net margin -4%) and EBITDA of ₹1.66 Lakh (EBITDA margin 4.2%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 17% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Welltass Pharmaceuticals Private Limited's registered office is in Greater Noida, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressVill – Begumpur, Greater Noida, Uttar Pradesh, India – 201306
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Welltass Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Welltass Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Welltass Pharmaceuticals Private Limited, buy the company report.
Financials of Welltass Pharmaceuticals Private Limited
FY 2025 filings availableWelltass Pharmaceuticals Private Limited reported revenue of ₹39.92 Lakh (down 6% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue fell 6% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 17%. EBITDA fell 59% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹1.66 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹1.59 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 4.2% | ||||
| Net Profit Margin | -4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Welltass Pharmaceuticals Private Limited, buy the company report.
Board of directors of Welltass Pharmaceuticals Private Limited
Welltass Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Moinuddin | Whole-Time Director | 18 Feb 2015 | 11 Years 8 Months | Current |
| Farhana Parveen | Director | 06 Jul 2016 | 10 Years 4 Months | Current |
Peer comparison
Welltass Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Steenbrass Pharmaceuticals Private Limited | ₹40.17 Lakh (FY 2015) | -12.0% | Mumbai, Maharashtra, India | |||
| Vitabolik Pharmaceuticals Private Limited | ₹39.95 Lakh (FY 2025) | -64.0% | Mumbai, Maharashtra, India | |||
| Welltass Pharmaceuticals Private Limitedthis company | ₹39.92 Lakh (FY 2025) | -₹1.59 Lakh | -4% | -6.0% | Greater Noida, Uttar Pradesh, India | |
| Coris Chemicals and Pharmaceuticals Private Limited | ₹39.7 Lakh (FY 2025) | 34.0% | Surat, Gujarat, India | |||
| Nihit Pharmaceuticals Private Limited | ₹39.68 Lakh (FY 2021) | 560.0% | Pune, Maharashtra, India |
To see the full peer comparison of Welltass Pharmaceuticals Private Limited, buy the company report.
Auditor
Welltass Pharmaceuticals Private Limited is audited by GUPTA GARG & AGRAWAL for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| GUPTA GARG & AGRAWAL | FY 2017 | 505762C |
Shareholding
The shareholding of Welltass Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Welltass Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Welltass Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Welltass Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Welltass Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AABCW6159Q1ZG | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Welltass Pharmaceuticals Private Limited, buy the company report.
Recent activity
Welltass Pharmaceuticals Private Limited has 5 board changes on record since 2015: 2 appointments and 3 cessations. The latest: Shafat Ali Khan ceased to be Director on 02 Jan 2021.
Frequently asked questions
Welltass Pharmaceuticals is an active private limited company based in Greater Noida, Uttar Pradesh, India. The company works in other wholesale, within the trading industry. It was incorporated on 18 February 2015 (11+ years old) and is registered under CIN U24233UP2015PTC069030.
Welltass Pharmaceuticals has 2 current directors:
- Moinuddin - Whole-Time Director
- Farhana Parveen - Director
The latest financial statements of Welltass Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Welltass Pharmaceuticals is 09AABCW6159Q1ZG, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Welltass Pharmaceuticals is U24233UP2015PTC069030. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Welltass Pharmaceuticals was incorporated on 18 February 2015, making it 11+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Welltass Pharmaceuticals by revenue are Steenbrass Pharmaceuticals Private Limited, Vitabolik Pharmaceuticals Private Limited, Coris Chemicals and Pharmaceuticals Private Limited, Nihit Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Shafat Ali Khan ceased to be Director on 02 Jan 2021. Amir Ali Khan ceased to be Additional Director on 06 Jul 2016. Farhana Parveen was appointed as Director on 06 Jul 2016. Welltass Pharmaceuticals has 5 board changes on record in total.
The registered office of Welltass Pharmaceuticals is at Vill – Begumpur, Greater Noida, Uttar Pradesh, India – 201306.
Welltass Pharmaceuticals operates in the trading industry, in the other wholesale segment.
The compliance status of Welltass Pharmaceuticals is compliant as of 17 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
